Stress and Cancer: A Surprising Connection and Potential New Treatments
Stress doesn’t just affect mood; it impacts the entire body. Research now suggests that stress can even influence cancer progression, potentially increasing the ability of tumors to metastasize. A recent study from the Dana-Farber Cancer Institute, published in Nature, details how tumor cells react to stress and identifies a drug that could counteract this process.
Understanding Stress: Acute vs. Chronic
It’s important to understand that there are different types of stress. Acute stress is short-term, triggered by immediate situations like a minor loss or traffic congestion. Chronic stress, however, extends over time, rooted in deeper issues like financial hardship or the loss of a loved one.
This research focuses on the impact of chronic stress on cancer cells, specifically in triple-negative breast cancer, colorectal cancer and melanoma. It’s crucial to note that this doesn’t indicate stress causes cancer directly, but that stress hormones can influence the body’s response to a tumor.
How Stress Hormones Shield Cancer Cells
When a person is stressed, the body produces more cortisol, a stress hormone belonging to the glucocorticoid group. These hormones can activate glucocorticoid receptors within cells. Researchers believe this activation may help some cancer cells evade the immune system, which is responsible for detecting and destroying them before they can spread.
When these cells avoid detection, they can travel to other parts of the body, leading to metastasis. Scientists at the Dana-Farber Institute have developed a technique to observe individual cells breaking away from a breast tumor and implanting in the lungs – a process called micrometastasis. This step is critical for cancer spread but has been difficult to target due to a lack of visualization technology.
Micrometastasis and the Role of Glucocorticoid Receptors
The study revealed that these micrometastatic cells have active glucocorticoid receptors (GRs). These receptors can be activated by stress hormones, allowing the cancer to metastasize.
To prevent this activation, researchers tested the drug mifepristone on mice with triple-negative breast cancer. The results, published in Nature, showed that the treatment reduced metastasis and increased survival rates by around 50% in the rodents.
Future Directions and Human Trials
While these findings are promising, it’s important to remember that the research is still in its early stages. Human trials are needed to determine if mifepristone or similar drugs will have the same effect in people. Researchers are currently seeking funding to initiate a clinical trial led by academic investigators at the Dana-Farber Cancer Institute.
The Broader Implications for Cancer Treatment
This research opens up new avenues for developing drugs that could prevent metastasis in cancer patients. Understanding the interplay between stress, hormones, and the immune system could lead to more targeted and effective cancer therapies.
Did you know?
Engineered “natural killer” cells are also being explored as a potential cancer treatment, according to recent research from MIT News.
Frequently Asked Questions
- Does stress cause cancer?
- There is no evidence that stress directly causes cancer. However, studies suggest stress hormones may influence how tumor cells interact with the immune system.
- Is there a treatment available based on this research?
- Researchers tested mifepristone in mice with triple-negative breast cancer, reducing metastasis and increasing survival. Human trials are still needed.
Explore further: Learn more about recent advancements in cancer treatment here.
Have thoughts on this research? Share your comments below!
Keep reading
